Astrazeneca (AZN) Change in Intangibles (2009 - 2026)

Astrazeneca's Change in Intangibles history runs 17 years deep, the most recent figure standing at -$991.0 million for Q1 2026.

• In Q1 2026, Change in Intangibles fell 83.52% year-over-year to -$991.0 million; the TTM figure through Mar 2026 stood at -$3.5 billion (down 76.07% YoY), while the FY2025 annual figure was -$3.1 billion, down 16.27% from the prior year.
• Change in Intangibles was -$991.0 million for Q1 2026 at Astrazeneca, down from -$251.0 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of -$144.0 million in Q1 2022 to a low of -$1.3 billion in Q2 2025.
• Historically, Change in Intangibles has averaged -$662.9 million across 5 years, with a median of -$540.0 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Change in Intangibles tumbled 749.31% in 2023, then surged 54.55% in 2025.
• A 5-year view of Change in Intangibles shows it stood at -$290.0 million in 2022, then advanced by 26.55% to -$213.0 million in 2023, then dropped by 15.96% to -$247.0 million in 2024, then retreated by 1.62% to -$251.0 million in 2025, then tumbled by 294.82% to -$991.0 million in 2026.
• The last three Change in Intangibles figures came in at -$991.0 million (Q1 2026), -$251.0 million (Q4 2025), and -$1.0 billion (Q3 2025), per Business Quant data.